LIBRA™ -Antibody Engineering Platform for antibody humanization, maturation, and rational evolution

About LIBRA™

LIBRA-Antibody Engineering Platform is GeneMedi’s innovative antibody engineering platform.
LIBRA is developed with the characteristics: Light, Intelligent, Balanced, Rational, and Algorithm-driven.
LIBRA, (♎) is also Latin, meaning “Balance” in astrology.

LIBRA HuEasy Monoclonal antibody (mab) humanization service (fully humanized ab)

With extensive in-house data and know-how in protein engineering as well as antibody research and development, GeneMedi developed a unique big-data-driven mature antibody humanization technology, LIBRA HuEasy. GM’s LIBRA HuEasy technology combines artificial intelligence (AI) and prior wet data to form a self-evolution antibody humanization Algorithm. We are committed to offering an Easier, Faster, higher efficient humanization service and solution to balance high affinity with low immunogenicity for your parental antibodies.

This site uses cookies to offer you a better browsing experience. By browsing this website, you agree to our use of cookies.